Circulating tumor cells in breast cancer
Copyright: © 2020 Revista Medica del Instituto Mexicano del Seguro Social..
Breast cancer is the most recurrent cancer in female population, its mortality is related to the presence of distant metastases. Distant metastasis begins as a small group of cells that spread regionally and remotely from the site of primary origin. Circulating tumor cells (CTC) are present in the blood of cancer patients and are therefore considered disease markers and precursors of metastasis. It is trascendental the review of the molecular aspects of the metastatic process, the available techniques for the enrichment, identification and molecular characterization of CTC, as well as some examples of its usefulness and clinical application in patients with breast cancer, including aspects related to perioperative management during breast cancer surgery.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
|---|---|
| Enthalten in: |
Revista medica del Instituto Mexicano del Seguro Social - 58(2020), Supl 1 vom: 27. Apr., Seite S51-S61 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Células tumorales circulantes en cáncer de mama |
|---|
| Beteiligte Personen: |
López-Muñoz, Eunice [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarkers |
|---|
| Anmerkungen: |
Date Revised 27.10.2021 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.24875/RMIMSS.M20000115 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332353966 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332353966 | ||
| 003 | DE-627 | ||
| 005 | 20231225215412.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.24875/RMIMSS.M20000115 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1107.xml |
| 035 | |a (DE-627)NLM332353966 | ||
| 035 | |a (NLM)34695316 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a López-Muñoz, Eunice |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Circulating tumor cells in breast cancer |
| 246 | 3 | 3 | |a Células tumorales circulantes en cáncer de mama |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 27.10.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright: © 2020 Revista Medica del Instituto Mexicano del Seguro Social. | ||
| 520 | |a Breast cancer is the most recurrent cancer in female population, its mortality is related to the presence of distant metastases. Distant metastasis begins as a small group of cells that spread regionally and remotely from the site of primary origin. Circulating tumor cells (CTC) are present in the blood of cancer patients and are therefore considered disease markers and precursors of metastasis. It is trascendental the review of the molecular aspects of the metastatic process, the available techniques for the enrichment, identification and molecular characterization of CTC, as well as some examples of its usefulness and clinical application in patients with breast cancer, including aspects related to perioperative management during breast cancer surgery | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Biomarkers | |
| 650 | 4 | |a Breast Neoplasms | |
| 650 | 4 | |a Circulating | |
| 650 | 4 | |a Neoplasm Metastasis | |
| 650 | 4 | |a Neoplastic Cells | |
| 700 | 1 | |a Mejía-Terrazas, Gabriel Enrique |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista medica del Instituto Mexicano del Seguro Social |d 2005 |g 58(2020), Supl 1 vom: 27. Apr., Seite S51-S61 |w (DE-627)NLM156363798 |x 0443-5117 |7 nnns |
| 773 | 1 | 8 | |g volume:58 |g year:2020 |g number:Supl 1 |g day:27 |g month:04 |g pages:S51-S61 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.24875/RMIMSS.M20000115 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 58 |j 2020 |e Supl 1 |b 27 |c 04 |h S51-S61 | ||